Relationship between moderate alcohol consumption and all-cause mortality across different stages of

Zhuotong Wang1, Lingyuan Hu1, Aomiao Chen1

  • 1Department of Endocrinology & Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China; The First School of Clinical Medicine, Southern Medical University, Guangzhou, China; De Feng Academy, Southern Medical University, Guangzhou, China.

Insights

Moderate alcohol consumption may increase all-cause mortality, particularly in certain stages of Cardiovascular-Kidney-Metabolic Syndrome (CKM). This study suggests caution even with moderate drinking for both men and women.

Area of Science:

  • Cardiovascular Health
  • Metabolic Syndrome Research
  • Public Health & Epidemiology

Background:

  • The health impacts of moderate alcohol intake are debated.
  • Cardiovascular-Kidney-Metabolic Syndrome (CKM) is an emerging health concept.
  • Existing research lacks clarity on alcohol's role in CKM.

Purpose of the Study:

  • To examine moderate alcohol consumption's link with all-cause mortality.
  • To investigate this association across different CKM stages.
  • To validate findings in UK Biobank and NHANES populations.

Main Methods:

  • Analysis of UK Biobank (112,207 participants) and NHANES (10,904 participants) cohorts.
  • Stratification by CKM stages and sex.
  • Use of multiple covariates and restricted cubic spline (RCS) curves.

Main Results:

  • UK Biobank showed moderate drinking linked to higher all-cause mortality; NHANES did not.
  • Positive correlation found in CKM stages II (both sexes) and IV (males).
  • RCS curves indicated higher female sensitivity to alcohol's mortality risk.

Conclusions:

  • A positive association between alcohol consumption and all-cause mortality was observed.
  • Findings suggest caution regarding moderate alcohol intake for both genders.
  • Minimizing alcohol consumption is recommended despite potential prior perceived benefits.
Abstract

Related Concept Videos

Hypothesis Test for Test of Independence01:16

Hypothesis Test for Test of Independence

The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...
7.4K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
339
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
552
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
878
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
589